المؤلفون: Riger To, C Meyer, E.A. Matveeva, A.E. Drui, R Marschalek, Grigory Tsaur, O. R. Arakaev, OI Sokova, SA Rumyantsev, Larisa Fechina, EV Fleischman, O. V. Streneva, Egor Shorikov, Solodovnikov Ag, Savel'ev Li, AM Kustanovich, YuV Ol’shanskaya, Alexander Popov, O. V. Nikulina

المصدر: Kliničeskaâ onkogematologiâ, Vol 9, Iss 1, Pp 22-29 (2016)

مصطلحات موضوعية: Genetics, Acute leukemia, business.industry, infants, 11q23/MLL rearrangements, Treatment outcome, Breakpoint, Hematology, 030204 cardiovascular system & hematology, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, MLL-Baby, 03 medical and health sciences, genomic DNA, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, hemic and lymphatic diseases, treatment outcome, Medicine, acute leukemia, business, Mll gene

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e4f49337fd2669115a53e5a5cc1d0a5
http://bloodjournal.ru/en/relation-between-genomic-dna-breakpoints-in-mll-gene-and-treatment-outcome-in-infants-with-acute-leukemia/